EGFR and pancreatic neoplasm: More recently, in another study overexpression of ITGA3 has been associated with a poor prognosis in patients with pancreatic cancer and ablation of ITGA3 was reported to be accompanied by a significant decrease in the EGFR expression and tumour growth37.